Adam Bond

Adam is a final year PhD student in the research group of Professor Alessio Ciulli, based at the new Centre for Targeted Protein Degradation (CeTPD) at the University of Dundee. His research interests include medicinal chemistry and biophysics, with goals in his PhD to develop new ligand-inducible degron systems and investigating how improving PROTAC physicochemical properties can lead to increased cellular activity. He led the chemistry in the development of BromoTag, a new bump-&-hole-PROTAC based inducible degron system.

Adam graduated from Newcastle University in 2018 with an integrated Master’s in Chemistry with Medicinal Chemistry. For his Master’s year, he was under the supervision of Dr Ian Hardcastle at the Northern Institute of Cancer Research, where he worked on developing MDM2/AR receptor PROTACs.